U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ILIXADENCEL
INN  
Official Name English
ilixadencel [INN]
Common Name English
Ilixadencel [WHO-DD]
Common Name English
CELL THERAPY CONSISTING OF PRO-INFLAMMATORY MONOCYTE-DERIVED DENDRITIC CELLS (MODCS), ISOLATED FROM AN ALLOGENEIC HUMAN HEALTHY BLOOD DONOR AND EX-VIVOSTIMULATED WITH RESIQUIMOD (R848), POLYINOSINIC-POLYCYTIDYLIC ACID (POLY(I:C)) AND INTERFERON GAMMA (IF
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 864821
Created by admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
FDA ORPHAN DRUG 788320
Created by admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
FDA ORPHAN DRUG 796120
Created by admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
Code System Code Type Description
INN
10532
Created by admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
PRIMARY
FDA UNII
PY29292DVJ
Created by admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
PRIMARY
NCI_THESAURUS
C99902
Created by admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
PRIMARY
ACTIVE MOIETY
ILIXADENCEL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966